---
title: "Statistical Methods for Composite Endpoints: Win Ratio and Beyond"
subtitle: "Chapter 5 - Discussions"
css: style.css
csl: apa.csl
author:
  name: Lu Mao
  affiliations: 
    - name: Department of Biostatistics & Medical Informatics
    - University of Wisconsin-Madison
    - April 25, 2024
  email: lmao@biostat.wisc.edu
format: 
  revealjs:
    theme: simple
    auto-stretch: false
    # incremental: true   
editor: visual
execute: 
  eval: false
  echo: true
include-in-header:
  - text: |
      <style type="text/css">
      ul li ul li {
        font-size: 0.78em;
      }
      .custom-small table {
        font-size: .55em
      }
      </style>
bibliography: references.bib
# title-slide-attributes: 
#   data-background-image: jsm_logo.png
#   data-background-size: 20%
#   data-background-position: 2% 2%
---

# Open Problems

## Covariate Adjustment

-   **Different from regression**
    -   **Marginal estimands** for $\mathcal H^{*(1)}$ vs $\mathcal H^{*(0)}$, not conditioning on $Z$
    -   **Gain efficiency** when outcome-covariate model is true, otherwise still valid (robustness)
    -   **Standard endpoints**
        -   Continuous, binary, univariate survival, etc. [@tsiatis2008; @wang2021; @ye2022]
        -   FDA recommendation [@fda:2023]
-   **Challenges with WR**
    -   $U$-statistic structure
    -   Lack of likelihood structure

## Interim Analysis

-   **Purpose**
    -   Analyze interim data for evidence of efficacy/futility $\to$ stop trial early
    -   Univariate survival: information accrued $\propto$ number of events
-   **Challenges with WR**
    -   Information time not event-driven
        -   Case study: RMST [@luo2019; @lu2021]
    -   Correlations between component events
        -   *Dependent* increments

## Meta Analysis

-   **Challenges**
    -   Primary studies *not* reporting win-loss measures
    -   Primary studies over *different* time spans
    -   Primary studies with *different* definitions of win/loss

-   [`WinKM`](https://lmaowisc.github.io/winkm/){target="_blank"}: A toolkit to start
    -   Calculate win-loss statistics based on 
        -   KM estimates for OS and EFS
        -   At-risk table at selected time points 
        -   Total event counts (reported in the CONSORT diagram or results section)


# Conclusion

## Summary (I)

-   **Composite endpoints**
    -   Death + hospitalization/progression/relapse
    -   Regulatory recommendation
-   **Traditional**
    -   **Time to first**: death = nonfatal (`survival::coxph()`)
    -   **Weighted total**: death = $w_D\times$ nonfatal (`Wcompo::compoML()`)
-   **Hierarchical**
    -   Win ratio, net benifit, win odds: death \> nonfatal
    -   Estimand issue - ICH E9 (R1)

## Summary (II)

-   **Win ratio test**
    -   **Standard**: death \> one nonfatal event
    -   **Recurrent events**: death \> frequency \> time to last/first event
        -   `WR::WRrec(ID, time, status, trt, strata)`
    -   **Sample size calculations**
        -   **Gumbel-Hougaard copula** for death & nonfatal event
        -   Baseline parameters + component-wise HR
        -   `WR::WRSS(xi, ...)`
-   **RMT-IF**
    -   Net average win time on hierarchical states by $\tau$
        -   `rmt::rmtfit(id, time, status, trt)`

## Summary (III)

-   **While-alive weighted events**
    -   Compensate for differential survival by $\tau$
        -   `WA::LRfit(id, time, status, trt, Dweight)`
-   **WR regression**
    -   PW model $$
        WR(t\mid Z_i, Z_j;\mathcal W)=\exp\left\{\beta^{\rm T}\left(Z_i- Z_j\right)\right\}
        $$
        -   $\exp(\beta)$: WRs with unit increases in covariates
        -   `WR::pwreg(ID, time, status, Z, strata)`
-   **Regularization**
    -   Elastic net-type penalty (`WRNet`)

## Learning Objectives

-   **Objectives**
    
    -   Identify statistical and regulatory challenges with composite endpoints
    -   Apply key methods such as hypothesis testing, power analysis, and regression
    -   Gain hands-on experience with real data using R packages


Visit back at <https://lmaowisc.github.io/ce/>

## Acknowledgments

-   **Funding**

    -   [R01HL149875](https://reporter.nih.gov/search/9aSu5u3xlE26GrjbF_4cBg/project-details/10734551){target="_blank"} (11/2019 -- 7/2028)
    -   [DMS2015526](https://www.nsf.gov/awardsearch/showAward?AWD_ID=2015526){target="_blank"} (7/2020 -- 6/2024) ![](images/funds.png){fig-align="center" width="70%"}

-   **Collaborators**

    -   [KyungMann Kim](https://biostat.wiscweb.wisc.edu/staff/kim-kyungmann/){target="_blank"}, [Tuo Wang](https://tuowang.rbind.io/){target="_blank"}, Po-Kuei Chen, Gaohong Dong, Bo Huang, Yi Li, [Xinran Miao](https://xinranmiao.github.io/){target="_blank"}, [Danyu Lin](https://dlin.web.unc.edu/){target="_blank"}, etc.

## References
